Portal de Periódicos da CAPES

The ‘normobaric oxygen paradox’: a simple way to induce endogenous erythropoietin production and concomitantly raise hemoglobin levels in anemic patients

2010; Wiley; Volume: 11; Issue: 1 Linguagem: Inglês

10.1111/j.1778-428x.2010.01127.x

1778-428X

Costantino Balestra, Peter Germonpré, Pierre Lafère, Yannick Ciccarella, Philippe Van der Linden,

Acute Ischemic Stroke Management

Transfusion Alternatives in Transfusion MedicineVolume 11, Issue 1 p. 39-42 The 'normobaric oxygen paradox': a simple way to induce endogenous erythropoietin production and concomitantly raise hemoglobin levels in anemic patients COSTANTINO BALESTRA phd, Corresponding Author COSTANTINO BALESTRA phd Environmental & Occupational Physiology Laboratory, Haute Ecole Paul Henri Spaak;Prof. C. Balestra, Pôle Universitaire de Bruxelles Wallonie, Haute Ecole Paul Henri Spaak, 1160 Auderghem, Brussels, BelgiumE-mail: [email protected]Search for more papers by this authorPETER GERMONPRÉ md , PETER GERMONPRÉ md Environmental & Occupational Physiology Laboratory, Haute Ecole Paul Henri Spaak; Center for Hyperbaric Oxygen Therapy, Queen Astrid Military Hospital;Search for more papers by this authorPIERRE LAFERE md , PIERRE LAFERE md Environmental & Occupational Physiology Laboratory, Haute Ecole Paul Henri Spaak; Center for Hyperbaric Oxygen Therapy, Queen Astrid Military Hospital;Search for more papers by this authorYANNICK CICCARELLA md , YANNICK CICCARELLA md Anesthesiology Department, Brugmann University Hospital, Brussels, BelgiumSearch for more papers by this authorPHILIPPE VAN DER LINDEN md, phd, PHILIPPE VAN DER LINDEN md, phd Anesthesiology Department, Brugmann University Hospital, Brussels, BelgiumSearch for more papers by this author COSTANTINO BALESTRA phd, Corresponding Author COSTANTINO BALESTRA phd Environmental & Occupational Physiology Laboratory, Haute Ecole Paul Henri Spaak;Prof. C. Balestra, Pôle Universitaire de Bruxelles Wallonie, Haute Ecole Paul Henri Spaak, 1160 Auderghem, Brussels, BelgiumE-mail: [email protected]Search for more papers by this authorPETER GERMONPRÉ md , PETER GERMONPRÉ md Environmental & Occupational Physiology Laboratory, Haute Ecole Paul Henri Spaak; Center for Hyperbaric Oxygen Therapy, Queen Astrid Military Hospital;Search for more papers by this authorPIERRE LAFERE md , PIERRE LAFERE md Environmental & Occupational Physiology Laboratory, Haute Ecole Paul Henri Spaak; Center for Hyperbaric Oxygen Therapy, Queen Astrid Military Hospital;Search for more papers by this authorYANNICK CICCARELLA md , YANNICK CICCARELLA md Anesthesiology Department, Brugmann University Hospital, Brussels, BelgiumSearch for more papers by this authorPHILIPPE VAN DER LINDEN md, phd, PHILIPPE VAN DER LINDEN md, phd Anesthesiology Department, Brugmann University Hospital, Brussels, BelgiumSearch for more papers by this author First published: 04 April 2010 https://doi.org/10.1111/j.1778-428X.2010.01127.xCitations: 11Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Bursi F, Barbieri A, Politi L, et al. Perioperative red blood cell transfusion and outcome in stable patients after elective major vascular surgery. Eur J Vasc Endovasc Surg 2009; 37: 311–18. 2 Ruhl H, Bein G, Sachs UJ. Transfusion-associated graft-versus-host disease. Transfus Med Rev 2009; 23: 62–71. 3 Merchionne F, Dammacco F. Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectives. Br J Haematol 2009; 146: 127–41. 4 Balestra C, Germonpre P, Poortmans JR, Marroni A. Serum erythropoietin levels in healthy humans after a short period of normobaric and hyperbaric oxygen breathing: the 'normobaric oxygen paradox'. J Appl Physiol 2006; 100: 512–18. 5 Haddad JJ. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell Signal 2002; 14: 879–97. 6 Haddad JJ, Land SC. O(2)-evoked regulation of HIF-1alpha and NF-kappaB in perinatal lung epithelium requires glutathione biosynthesis. Am J Physiol Lung Cell Mol Physiol 2000; 278: L492–503. 7 McPherson RJ, Juul SE. Recent trends in erythropoietin-mediated neuroprotection. Int J Dev Neurosci 2008; 26: 103–11. 8 Riksen NP, Hausenloy DJ, Yellon DM. Erythropoietin: ready for prime-time cardioprotection. Trends Pharmacol Sci 2008; 29: 258–67. 9 Hare GM, Tsui AK, McLaren AT, et al. Anemia and cerebral outcomes: many questions, fewer answers. Anesth Analg 2008; 107: 1356–70. 10 Burk R. Oxygen breathing may be a cheaper and safer alternative to exogenous erythropoietin (EPO). Med Hypotheses 2007; 69: 1200–4. 11 Bokemeyer C, Aapro MS, Courdi A, et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 2007; 43: 258–70. 12 Corwin HL, Gettinger A, Pearl RG, et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 2002; 288: 2827–35. 13 Port RE, Ding RW, Fies T, Scharer K. Predicting the time course of haemoglobin in children treated with erythropoietin for renal anaemia. Br J Clin Pharmacol 1998; 46: 461–6. Citing Literature Volume11, Issue1March 2010Pages 39-42 ReferencesRelatedInformation